UPDATED May 04, 2024
Discover French Pharmaceuticals & Biotech Growth Stocks that are on the CAC. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
PHXM | €2.88 | -2.5% | -63.5% | €17.5m | €6.85 | PS13.2x | E144.6% | n/a | ||
ALDVI | €1.65 | -1.9% | -51.9% | €20.2m | €6.90 | PS6.2x | E118.1% | n/a | ||
ADOC | €8.47 | 0.5% | 164.7% | €121.0m | €9.70 | PS20x | E104.5% | n/a | ||
ALONC | €14.42 | 0% | 57.3% | €99.4m | €18.64 | PS3x | E101.2% | n/a | ||
OSE | €6.20 | 11.5% | 63.4% | €133.7m | €7.15 | PS60x | E92.9% | n/a | ||
ALPAT | €11.40 | 8.6% | -15.6% | €12.4m | €11.50 | PS5.3x | E92.7% | n/a | ||
ALVAL | €4.13 | 5.9% | 11.6% | €65.1m | €10.07 | PS9.6x | E87.5% | n/a | ||
EAPI | €2.89 | 4.8% | -72.6% | €274.3m | €4.72 | PB0.3x | E85.2% | n/a | ||
ALACT | €0.38 | 14.3% | -93.1% | €5.0m | €1.00 | PB13.7x | E81.5% | n/a | ||
ALPHE | €2.00 | 2.6% | -53.6% | €14.4m | €5.80 | PS4.6x | E78.8% | n/a | ||
MEDCL | €14.30 | 13.0% | 60.5% | €411.1m | €17.15 | PS29.1x | E67.8% | n/a | ||
ALCLS | €2.76 | 17.7% | 54.6% | €198.0m | n/a | PS23.2x | E56.2% | n/a | ||
ALBPS | €0.79 | -14.1% | -93.4% | €2.3m | n/a | PE-0.1x | E56.2% | n/a | ||
GNFT | €3.24 | 0.8% | -16.5% | €160.8m | €9.38 | PS4.7x | E54.7% | n/a | ||
DBV | €1.20 | 0.8% | -60.3% | €115.1m | €4.78 | PS7.9x | E53.3% | n/a | ||
VLA | €3.43 | -0.3% | -42.0% | €476.6m | €8.95 | PS3.1x | E50.9% | n/a | ||
ALSEN | €0.70 | -0.6% | 160.5% | €193.4m | €2.38 | PS34.8x | E42.8% | n/a | ||
ALERS | €14.50 | 1.5% | -15.3% | €148.3m | €30.00 | PE30.9x | E36.3% | n/a | ||
IPH | €2.21 | -1.8% | -19.2% | €178.3m | €6.27 | PS2.9x | E33.0% | n/a | ||
DIM | €208.30 | 0% | -18.5% | €20.3b | €251.33 | PE79.6x | E23.3% | 0.3% | ||
ERF | €56.68 | 0.07% | -12.8% | €10.9b | €60.88 | PE42.6x | E20.4% | 0.9% | ||
IVA | €3.16 | 5.3% | 31.7% | €164.4m | €13.83 | PS7.1x | E17.6% | n/a | ||
SAN | €91.30 | 0.08% | -10.1% | €114.0b | €108.06 | PE25.1x | E16.6% | 4.1% | ||
VIRP | €355.50 | 1.9% | 20.5% | €3.0b | €368.00 | PE24.5x | E11.2% | 0.4% |